Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study

Completed

• Conditions: Prostate Cancer
• Interventions: Device: Hand held transrectal Combined Ultrasound and photoacoustic imaging (PAI) probe

• Registration Number: NCT01551576
• Lead Sponsor: Stanford University

Brief Summary

The purpose of our study is to image human prostate tissue using a transrectal photoacoustic imaging probe.

Detailed Description

PRIMARY OBJECTIVE(S):

The primary objective of this pilot study is to assess PAI-performance in a clinical setting to understand limitations of our current PAI instrumentation and to help improve the next-generation design.

SECONDARY OBJECTIVE(S):

To do preliminary evaluations of oxygen saturation in lesions based on PAI-measurements in order to distinguish malignant from benign prostatic tissue as a basis for future studies.

Study Timeline

• Study First Submitted: 2012-03-08
• Study First Submitted QC: 2012-03-09
• Study First Posted: 2012-03-12
• Study Start: 2014-02
• Primary Completion: 2019-12-16
• Study Completion: 2019-12-16
• Status Verified: 2021-10
• Last Update Submitted: 2021-10-28
• Last Update Posted: 2021-11-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 20

Inclusion Criteria

• Consent signed
• Male >= 18 and <= 80 years of age
• Patients must have an elevated PSA And/ Or Abnormal digital rectal exam Or Other indication for prostate biopsy Or Patients with biopsy proven prostate cancer who are scheduled for prostatectomy.

Read More

Exclusion Criteria

• History of prostatectomy or other surgical history that would preclude transrectal imaging (i.e. abdominal perineal resection), anal stenosis/stricture disease
• Men with anatomic abnormalities or previous surgical history that make transrectal imaging impossible (for example, men with previous abdominal-perineal bowel resections or anal atresia/stenosis)

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
photoacoustic imaging (PAI)	Hand held transrectal Combined Ultrasound and photoacoustic imaging (PAI) probe	Men seen in the urology clinic for elevated PSA and/or abnormal digital rectal exam (DRE) will be offered PAI at the time of transrectal ultrasound guided biopsy, which is standard of care. In addition, patients with a biopsy proven prostate cancer may also be approached for this PAI scan

Primary Outcome Measures

Name	Time	Method
lesion signal intensity on Photoacoustic Imaging (PAI) in relation to different lesion characteristics and the surrounding tissues	36 months	measure of the lesion signal intensity on PAI in relation to different lesion characteristics and the surrounding tissues. The average signal intensity (or more specifically the SNR) of the lesions measured in dB) will be tabulated against lesion depth from the transducer, and lesion size, based on ultrasound measurements

Secondary Outcome Measures

Name	Time	Method
Measures of hypoxia in the lesion	36 months	total lesion hemoglobin concentration (HbT) at PAI and percentage SO2 (oxygen saturation) in region of interest (ROI) (average and maximum) which will be tested against lesion characteristics based on histology at pathological examination of the biopsy and/or prostatectomy specimen if the patients proceed to have radical prostatectomy performed

Trial Locations

Locations (1)

Stanford University Cancer Institute; 🇺🇸 Stanford, California, United States